Health-related quality of life (EuroQol 5D-5L) in patients with autoimmunity in the context of immunotherapy: a large dataset comprising cancer patients after cessation of checkpoint inhibitor therapy and patients with autoimmune diseases

Published: 28 October 2022| Version 2 | DOI: 10.17632/jvs782kvw8.2
Contributors:
,
,
,
,
,
,
,
,

Description

This dataset contains demographic, clinical, and health-related quality of life (HRQoL) data from 2905 patients including 200 cancer patients after immune checkpoint inhibitor (ICI) cessation and 2705 patients with a wide variety of autoimmune diseases.

Files

Steps to reproduce

Within this multicenter, cross-sectional survey study data were collected questionnaire-based in cancer patients (ICI-patients) ≥ 18 years of age who had received at least one dose of ICI with ≥ 12 weeks since ICI discontinuation. Patients with autoimmune diseases (AI-patients) were ≥ 18 years, had at least one autoimmune disease and had never received ICI. ICI-patients were recruited in three skin cancer centers and via support groups. AI-patients were recruited in an outpatient clinic for internal medicine and via support groups.

Categories

Immunology, Cancer, Pituitary Gland, Autoimmunity, Rheumatoid Arthritis, Ipilimumab, Pembrolizumab, Nivolumab, Autoimmune Disorder, Systemic Lupus Erythematosus, Crohn's Disease, Ulcerative Colitis, Type 1 Diabetes, Immune Disorder, Multiple Sclerosis, Immunotherapy, Side Effect, Adverse Event, Ankylosing Spondylitis, Blood Disorder, Gastritis, Primary Biliary Cirrhosis, Primary Sclerosing Cholangitis, Polyneuropathy, Addison's Disease, Hyperthyroidism, Autoimmune Hepatitis, Melanoma, Lichen, Dermatomyositis, Psoriatic Arthritis, Hypothyroidism, Myositis, Myasthenia gravis, Polymyositis, Atopic Dermatitis, Psoriasis, Vitiligo, Quality of Life, Sjogren's Syndrome, Systemic Sclerosis, Pemphigoid, Pulmonary Fibrosis, Guillain-Barre Syndrome, Adverse Effect, Sarcoidosis, Immune Checkpoint Blockade, EuroQol Five Dimensions Questionnaire, Giant Cell, Immunotherapy of Skin Cancer, Pemphigus, Bullous Disease, Polymyalgia Rheumatica, Immune Checkpoint Inhibitor

Licence